Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis

Figure 2

The number of inclusion bodies decreased with increasing NM concentrations. Under phase contrast microscopy, the number of inclusion bodies in 100 high power (40x) fields per well in duplicate wells for each NM concentration were numerated. Results represent data averaged from three separate experiments. NM, nafamostat mesylate.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us